Catalent
CTLT
#1803
Rank
โ‚น1.039 T
Marketcap
โ‚น5,724
Share price
0.00%
Change (1 day)
19.05%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น570.80. In 2023 the company made an earnings per share (EPS) of -โ‚น613.18 a decrease over its 2022 EPS that were of โ‚น204.69.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-14.03%
2023-โ‚น613.18-399.56%
2022โ‚น204.69-30.58%
2021โ‚น294.8779.67%
2020โ‚น164.12114.12%
2019โ‚น76.65-15%
2018โ‚น90.1775.44%
2017โ‚น51.40-22.97%
2016โ‚น66.73-59.56%
2015โ‚น165.02282.05%
2014โ‚น43.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น29.76-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น67.63-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
-โ‚น537.44-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
-โ‚น133.46-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA